PHSRX Mutual Fund

PHSRX Mutual Fund

NAV$63.71
See how much of PHSRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 47 of 47 holdings · as of Sep 30, 2026
PHSRX holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
LLY
Eli Lilly & CoHealth Care · Pharmaceuticals
12.93%		12.9%166,300$192.42MHealth CarePharmaceuticals
2
JNJ
Johnson & Johnson -Health Care · Pharmaceuticals
9.56%		22.5%537,443$142.28MHealth CarePharmaceuticals
Sector and industry · Pro
3
ABBV
AbbVie Inc.
7.11%		29.6%404,800$105.89M
4
UNH
Unitedhealth Group Inc
5.88%		35.5%238,560$87.57M
5
MRK
Merck & Company Inc
5.86%		41.3%599,771$87.15M
6
NVS
Novartis Ag Ordinary Shares
4.58%		45.9%477,742$68.11M
7
ISRG
Intuitive Surgical Inc
3.79%		49.7%138,620$56.37M
8
RO
Roche Holding Ag
3.57%		53.3%127,990$53.19M
9—AstraZeneca PLC
3.51%		56.8%323,524$52.24M
10
GILD
Gilead Sciences
3.31%		60.1%330,500$49.26M
11—Thermo Fisher
3.07%		63.2%67,760$45.74M
12—Vertex Pharmaceuticals Inc
2.65%		65.8%75,500$39.47M
13
MCK
Mckesson Corp.
2.32%		68.1%40,520$34.60M
14
ELV
Elevance Health Inc
2.27%		70.4%86,760$33.73M
15
CVS
Cvs Health Corp
2.16%		72.6%375,000$32.13M
16
BAYN
Bayer Ag
2.10%		74.7%580,055$31.31M
17
CAH
Cardinal Health
2.07%		76.7%138,500$30.82M
18
DXCM
Dexcom Inc.
1.87%		78.6%323,300$27.90M
19
WAT
Waters Corp.
1.72%		80.3%58,320$25.63M
20
EW
Edwards Lifesciences Corp
1.62%		81.9%280,100$24.18M
21—Argenx Se Common Stock EUR
1.60%		83.5%24,841$23.82M
22
BMY
Bristol-Myers Squibb Co.
1.57%		85.1%375,000$23.40M
23—Abbot Laboratories
1.43%		86.5%214,700$21.22M
24—Hoya Corp
1.31%		87.9%130,100$19.49M
25
PSDTX
Putnam Short Term Investment Fund
1.05%		88.9%15,576,425$15.58M
26
RVMD
Revolution Medicines Inc
0.97%		89.9%70,600$14.49M
27
INSM
Insmed Inc
0.96%		90.8%125,114$14.28M
28—Royalty Pharma PLC - Class A Shares
0.87%		91.7%221,800$12.94M
29—GSK plc
0.69%		92.4%425,516$10.27M
30—Chugai Pharmaceutical Co., Ltd.
0.64%		93.0%244,800$9.57M
31
PTGX
Protagonist Therapeutics Inc
0.62%		93.7%65,400$9.21M
32
LGND
Ligand Pharmaceuticals, Inc.
0.58%		94.2%27,700$8.65M
33
HUM
Humana Inc.
0.56%		94.8%22,000$8.39M
34—Caris Life Sciences Inc
0.55%		95.3%267,200$8.18M
35
VERA
Vera Therapeutics Inc Ser C Pc Pp
0.51%		95.9%237,300$7.66M
36
NUVB
Nuvation Bio Inc
0.49%		96.3%1,304,100$7.30M
37
CYTK
Cytokinetics Inc
0.48%		96.8%108,600$7.16M
38
RYTM
Rhythm Pharmaceuticals Inc
0.48%		97.3%74,900$7.13M
39
ESTA
Establishment Labs Holdings Inc
0.47%		97.8%109,800$7.05M
40
MMED
Minimed Group Inc
0.45%		98.2%346,400$6.74M
41
CELC
Celcuity Inc
0.44%		98.7%82,800$6.58M
42—Harrow Health Inc
0.43%		99.1%210,100$6.47M
43
TNGX
Tango Therapeutics Inc.
0.26%		99.4%156,000$3.89M
44
ACRS
Aclaris Therapeutics Inc
0.25%		99.6%708,400$3.73M
45DebtUnited States Treasury Bill 12/10/2026
0.20%		99.8%3,000,000$2.98M
46DebtU.S. Treasury Bill 2026-10-22
0.10%		99.9%1,540,000$1.54M
47—Citibank Na Boston Scientific Corp Strike 100.0 Expires 2027-01-15 Call
0.00%		99.9%169,544$1.1K
Not reported for this fund: share changes.
FundXLS Pro
See every sector, industry and share-change value
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

PHSRX Mutual Fund All Holdings

PHSRX holdings total 47 positions. The top 10 holdings account for 60.1% of the fund, led by Eli Lilly & Co at 12.9%, Johnson & Johnson - Common at 9.6%, Abbvie Inc. at 7.1%.

PHSRX portfolio concentration is relatively high, with the top 10 representing 60.1% of total assets. The largest sector exposure is Health Care at 78.0%.

PHSRX sectors provide a detailed breakdown. PHSRX overlap shows how holdings compare to other funds in your portfolio.